View Post Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living with HIV: Lipid Changes and Statin Underutilization. Clinical Drug Investigation, 41: 955-965. In by AHFSeptember 15, 2021
View Post Clinical Efficacy of Cefixime for the Treatment of Early Syphilis. Clinical Infectious Diseases, 73(5): 907-910. In by AHFSeptember 1, 2021
View Post Incarceration and COVID-19: Recommendations to Curb COVID-19 Disease Transmission in Prison Facilities and Surrounding Communities. International Journal of Environmental Research and Public Health, 18: 1-7. In by AHFSeptember 1, 2021
View Post Clinical Trial Protocol to Evaluate the Efficacy of Cefixime in the Treatment of Early Syphilis. Clinical Infectious Diseases, 73(5): 907-910. In by AHFSeptember 1, 2021
View Post Syndemics and Pre-Exposure Prophylaxis are Independently Associated with Rectal Immune Dysregulation in Sexual Minority Men. AIDS, 35(8): 1295-1300. In by AHFJuly 15, 2021
View Post To Dose-Adjust or Not to Dose-Adjust: Lamivudine Dose in Kidney Impairment. AIDS, 35: 1201-1208. In by AHFJuly 15, 2021
View Post Virologic Outcomes Among People Living With Human Immunodeficiency Virus With High Pretherapy Viral Load Burden Initiating on Common Core Agents. Open Forum Infectious Diseases, 8(8): 1-8. In by AHFJuly 15, 2021
View Post Cultural Adaptation and Psychometric Evaluation of the Kinyarwanda Version of the Problem Areas in Diabetes (PAID) Questionnaire. Health and Quality of Life Outcomes, 19: 1-12. In by AHFJuly 15, 2021
View Post Disseminated Gonococcal Infection: A Potential Marker of Failing Sexually Transmitted Infection Control and Prevention Services. Sexually Transmitted Infections, 98(3): 233. In by AHFJuly 1, 2021
View Post Improvement in Metabolic Health Parameters at Week 48 After Switching From a Tenofovir Alafenamide–Based 3- or 4-Drug Regimen to the 2-Drug Regimen of Dolutegravir/Lamivudine: The TANGO Study. Journal of Acquired Immune Deficiency Syndromes, 87(2): 794-800. In by AHFJune 15, 2021
